$68.49
0.30.44%
At Close: -
$68.70
0.210.31%
After Hours: 5:36 PM EDT
15 minutes delayed
Comments
Loading...
Unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Axonics (NASDAQ:AXNX) Stock, Analyst Ratings, Price Targets, Forecasts
Axonics Inc has a consensus price target of $72.13 based on the ratings of 18 analysts. The high is $80 issued by Truist Securities on October 17, 2022. The low is $65 issued by SVB Leerink on February 25, 2022. The 3 most-recent analyst ratings were released by RBC Capital, Truist Securities, and Truist Securities on February 29, 2024, January 16, 2024, and January 12, 2024, respectively. With an average price target of $71 between RBC Capital, Truist Securities, and Truist Securities, there's an implied 3.35% upside for Axonics Inc from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
RBC Capital
Truist Securities
Piper Sandler
Leerink Partners
Wells Fargo
1calculated from analyst ratings
Analyst Ratings for Axonics
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 05/06/2024 | Buy Now | — | Needham | Mike Matson | — | Reiterates | → Hold | Get Alert |
| 02/29/2024 | Buy Now | 3.35% | RBC Capital | Shagun Singh | → $71 | Reiterates | Sector Perform → Sector Perform | Get Alert |
| 01/17/2024 | Buy Now | — | Needham | Mike Matson | — | Downgrade | Buy → Hold | Get Alert |
| 01/16/2024 | Buy Now | 3.35% | Truist Securities | David Rescott | $73 → $71 | Downgrade | Buy → Hold | Get Alert |
| 01/12/2024 | Buy Now | 3.35% | Truist Securities | David Rescott | $73 → $71 | Downgrade | Buy → Hold | Get Alert |
| 01/12/2024 | Buy Now | — | CL King | Kristen Stewart | — | Downgrade | Buy → Neutral | Get Alert |
| 01/12/2024 | Buy Now | 3.35% | Piper Sandler | Adam Maeder | $75 → $71 | Downgrade | Overweight → Neutral | Get Alert |
| 01/12/2024 | Buy Now | 3.35% | Leerink Partners | Mike Kratky | → $71 | Downgrade | Outperform → Market Perform | Get Alert |
| 01/10/2024 | Buy Now | 3.35% | Wells Fargo | Larry Biegelsen | $68 → $71 | Downgrade | Overweight → Equal-Weight | Get Alert |
| 01/09/2024 | Buy Now | — | Wolfe Research | Mike Polark | — | Downgrade | Outperform → Peer Perform | Get Alert |
| 12/22/2023 | Buy Now | 6.26% | Truist Securities | David Rescott | $65 → $73 | Maintains | Buy | Get Alert |
| 10/31/2023 | Buy Now | 9.17% | Piper Sandler | Adam Maeder | $84 → $75 | Maintains | Overweight | Get Alert |
| 10/31/2023 | Buy Now | 0.44% | Morgan Stanley | Cecilia Furlong | $76 → $69 | Maintains | Overweight | Get Alert |
| 10/31/2023 | Buy Now | -8.3% | Needham | Mike Matson | $76 → $63 | Maintains | Buy | Get Alert |
| 10/16/2023 | Buy Now | 1.89% | Leerink Partners | Mike Kratky | → $70 | Initiates | → Outperform | Get Alert |
| 07/28/2023 | Buy Now | 1.89% | Baird | David Rescott | $69 → $70 | Maintains | Outperform | Get Alert |
| 07/28/2023 | Buy Now | 10.63% | Needham | Mike Matson | $73 → $76 | Maintains | Buy | Get Alert |
| 07/28/2023 | Buy Now | 3.35% | Keybanc | Matthew Mishan | $70 → $71 | Maintains | Overweight | Get Alert |
| 07/19/2023 | Buy Now | 0.44% | Baird | David Rescott | → $69 | Initiates | → Outperform | Get Alert |
| 07/14/2023 | Buy Now | 9.17% | Mizuho | Anthony Petrone | → $75 | Reiterates | Buy → Buy | Get Alert |
| 07/13/2023 | Buy Now | 1.89% | Keybanc | Matthew Mishan | → $70 | Initiates | → Overweight | Get Alert |
| 07/12/2023 | Buy Now | 9.17% | RBC Capital | Shagun Singh | $85 → $75 | Maintains | Outperform | Get Alert |
| 05/23/2023 | Buy Now | 9.17% | CL King | Kristen Stewart | → $75 | Initiates | → Buy | Get Alert |
| 05/15/2023 | Buy Now | 23.73% | RBC Capital | Shagun Singh | → $85 | Reiterates | Outperform → Outperform | Get Alert |
| 05/12/2023 | Buy Now | 6.26% | Needham | Mike Matson | → $73 | Reiterates | Buy → Buy | Get Alert |
| 05/02/2023 | Buy Now | 23.73% | RBC Capital | Shagun Singh | → $85 | Reiterates | → Outperform | Get Alert |
| 05/02/2023 | Buy Now | 6.26% | Needham | Mike Matson | $71 → $73 | Maintains | Buy | Get Alert |
| 04/17/2023 | Buy Now | 6.26% | Truist Securities | David Rescott | $82 → $73 | Maintains | Buy | Get Alert |
| 04/14/2023 | Buy Now | 9.17% | Mizuho | Anthony Petrone | → $75 | Initiates | → Buy | Get Alert |
| 03/24/2023 | Buy Now | 3.35% | Needham | Mike Matson | → $71 | Upgrade | Hold → Buy | Get Alert |
| 01/06/2023 | Buy Now | 10.63% | Morgan Stanley | Cecilia Furlong | $92 → $76 | Maintains | Overweight | Get Alert |
| 12/20/2022 | Buy Now | 19.36% | Truist Securities | David Rescott | $90 → $82 | Maintains | Buy | Get Alert |
| 11/01/2022 | Buy Now | 31% | Truist Securities | David Rescott | $80 → $90 | Maintains | Buy | Get Alert |
| 11/01/2022 | Buy Now | 31% | Wells Fargo | Larry Biegelsen | $83 → $90 | Maintains | Overweight | Get Alert |
| 10/21/2022 | Buy Now | 23.73% | RBC Capital | Shagun Singh | → $85 | Initiates | → Outperform | Get Alert |
| 10/17/2022 | Buy Now | 16.45% | Truist Securities | Richard Newitter | $85 → $80 | Maintains | Buy | Get Alert |
| 10/12/2022 | Buy Now | 9.17% | Jefferies | Matthew Taylor | → $75 | Initiates | → Hold | Get Alert |
| 10/11/2022 | Buy Now | 33.92% | Morgan Stanley | Cecilia Furlong | $80 → $92 | Maintains | Overweight | Get Alert |
| 10/10/2022 | Buy Now | — | Needham | Mike Matson | — | Downgrade | Buy → Hold | Get Alert |
| 10/05/2022 | Buy Now | 22.27% | Piper Sandler | Adam Maeder | $82 → $84 | Maintains | Overweight | Get Alert |
| 08/02/2022 | Buy Now | 23.73% | Truist Securities | Richard Newitter | $75 → $85 | Maintains | Buy | Get Alert |
| 08/02/2022 | Buy Now | 16.45% | Morgan Stanley | Cecilia Furlong | $73 → $80 | Maintains | Overweight | Get Alert |
| 08/02/2022 | Buy Now | 26.64% | Wells Fargo | Larry Biegelsen | $80 → $87 | Maintains | Overweight | Get Alert |
| 08/02/2022 | Buy Now | 19.36% | Piper Sandler | Adam Maeder | $77 → $82 | Maintains | Overweight | Get Alert |
| 08/02/2022 | Buy Now | 12.08% | Needham | Mike Matson | $60 → $77 | Maintains | Buy | Get Alert |
| 07/20/2022 | Buy Now | 9.17% | Truist Securities | Richard Newitter | $64 → $75 | Maintains | Buy | Get Alert |
| 07/15/2022 | Buy Now | 6.26% | Morgan Stanley | Cecilia Furlong | $69 → $73 | Maintains | Overweight | Get Alert |
| 05/06/2022 | Buy Now | -12.66% | Needham | Mike Matson | $62 → $60 | Maintains | Buy | Get Alert |
| 05/06/2022 | Buy Now | 12.08% | Piper Sandler | Adam Maeder | $75 → $77 | Maintains | Overweight | Get Alert |
| 04/06/2022 | Buy Now | 0.44% | Wolfe Research | Mike Polark | → $69 | Initiates | → Outperform | Get Alert |
| 02/25/2022 | Buy Now | -5.39% | SVB Leerink | Danielle Antalffy | $60 → $65 | Maintains | Outperform | Get Alert |
| 02/25/2022 | Buy Now | 0.44% | Morgan Stanley | David Lewis | $73 → $69 | Maintains | Overweight | Get Alert |
| 01/07/2022 | Buy Now | 6.26% | Morgan Stanley | David Lewis | $74 → $73 | Maintains | Overweight | Get Alert |
| 12/14/2021 | Buy Now | -9.75% | Needham | Mike Matson | — | Maintains | Buy | Get Alert |
| 11/05/2021 | Buy Now | 23.73% | SVB Leerink | Danielle Antalffy | — | Maintains | Outperform | Get Alert |
| 11/05/2021 | Buy Now | 3.35% | Needham | Mike Matson | — | Maintains | Buy | Get Alert |
| 08/09/2021 | Buy Now | 7.71% | Morgan Stanley | — | — | Maintains | Overweight | Get Alert |
| 08/06/2021 | Buy Now | 14.99% | Barclays | Gena Wang | — | Maintains | Overweight | Get Alert |
FAQ
What is the target price for Axonics (AXNX) stock?
The latest price target for Axonics (NASDAQ:AXNX) was reported by Needham on May 6, 2024. The analyst firm set a price target for $0.00 expecting AXNX to fall to within 12 months (a possible -100.00% downside). 18 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Axonics (AXNX)?
The latest analyst rating for Axonics (NASDAQ:AXNX) was provided by Needham, and Axonics reiterated their hold rating.
When was the last upgrade for Axonics (AXNX)?
The last upgrade for Axonics Inc happened on March 24, 2023 when Needham raised their price target to $71. Needham previously had a hold for Axonics Inc.
When was the last downgrade for Axonics (AXNX)?
The last downgrade for Axonics Inc happened on January 17, 2024 when Needham changed their price target from N/A to N/A for Axonics Inc.
When is the next analyst rating going to be posted or updated for Axonics (AXNX)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Axonics, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Axonics was filed on May 6, 2024 so you should expect the next rating to be made available sometime around May 6, 2025.
Is the Analyst Rating Axonics (AXNX) correct?
While ratings are subjective and will change, the latest Axonics (AXNX) rating was a reiterated with a price target of $0.00 to $0.00. The current price Axonics (AXNX) is trading at is $68.70, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.